Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Merchlinsky

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of General Virology|July 10, 2009
Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control proteinJoan E Adamo, Clement A Meseda, Jerry P Weir, et al.
The Journal of Infectious Diseases|October 2, 2002
Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine aloneClement A Meseda, Karen L Elkins, Michael J Merchlinsky, et al.
Vaccines|September 28, 2021
Selection of Filovirus Isolates for Vaccine Development ProgramsDaniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, et al.
MMWR. Morbidity and Mortality Weekly Report|June 2, 2022
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022Agam K Rao, Brett W Petersen, Florence Whitehill, et al.
Vaccines|June 24, 2022
Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure DevelopmentCaroline Carbonnelle, Marie Moroso, Delphine Pannetier, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of General Virology|July 10, 2009
Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control proteinJoan E Adamo, Clement A Meseda, Jerry P Weir, et al.
The Journal of Infectious Diseases|October 2, 2002
Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine aloneClement A Meseda, Karen L Elkins, Michael J Merchlinsky, et al.
Vaccines|September 28, 2021
Selection of Filovirus Isolates for Vaccine Development ProgramsDaniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, et al.
MMWR. Morbidity and Mortality Weekly Report|June 2, 2022
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022Agam K Rao, Brett W Petersen, Florence Whitehill, et al.
Vaccines|June 24, 2022
Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure DevelopmentCaroline Carbonnelle, Marie Moroso, Delphine Pannetier, et al.
Pageof 1